Skip to main content
logo
Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
4.950
-0.120 (-2.37%)
At close: Nov 5, 2026, 4:00 PM EST
4.950
0.00 (0.00%)
Pre-market: Nov 6, 2026, 4:33 AM EST

Cryo-Cell International Financials Overview

Millions USD. Fiscal year is Dec - Nov.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Revenue
31.1331.5731.9931.3430.3428.88
Revenue Growth
-1.96%-1.31%2.05%3.32%5.03%-7.26%
Gross Profit
20.0919.8324.0419.2221.5418.73
Operating Income
0.190.483.79-0.254.463.24
Net Income
-1.95-2.430.4-9.522.772.08
Earnings Per Share
-0.24-0.300.05-1.140.330.25
EPS Growth
----30.95%-44.44%

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Umbilical Cord Blood and Cord Tissue Stem Cell Service
30.8331.3831.5530.829.7728.4
Public Cord Blood Banking
0.180.130.370.480.460.38
Prepacyte CB
0.110.050.070.070.10.11
Total
31.1331.5731.9931.3430.3428.88

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash & Investments
4.233.33.51.11.728.34
Total Debt
8.8211.5612.9310.911.612.82
Net Cash (Debt)
-4.59-8.26-9.44-9.79-9.895.52
Net Cash Growth
-----31.08%
Net Cash Per Share
-0.57-1.02-1.15-1.17-1.170.66

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Operating Cash Flow
4.925.486.018.928.577.93
Capital Expenditures
-0.27-0.23-2.4-6.84-12.17-1.83
Free Cash Flow
4.655.253.612.08-3.66.09
Free Cash Flow Growth
-24.77%45.49%73.36%---27.19%

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Gross Margin
64.53%62.82%75.15%61.31%71.02%64.85%
Operating Margin
0.61%1.53%11.84%-0.79%14.70%11.20%
Pretax Margin
-6.13%-7.40%8.77%-42.64%10.94%9.04%
Profit Margin
-6.25%-7.70%1.26%-30.38%9.13%7.21%
FCF Margin
14.94%16.63%11.28%6.64%-11.85%21.09%

Dividends
Chart
Fiscal Year
FY 2025FY 2024
Period EndingNov '25 Nov '24
Dividend Per Share
0.4000.250
Dividend Per Share Growth
60.00%-
Dividend Yield
9.30%2.89%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PE Ratio
--173.84-13.4350.68
Forward PE
61.8856.0078.82252.0048.56-
P/FCF Ratio
8.586.6019.3821.31-17.33
PS Ratio
1.281.102.191.411.233.66